Back to search
Familial Frontotemporal Dementia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Frontotemporal Dementia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Frontotemporal Dementia trials you may qualify forPre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investiga…
The aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological…
This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron…
The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention…
The purpose of this study is to determine if intensive lowering of systolic blood pressure (SBP), using FDA approved medications (antihypertensive), reduces Alz…
The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to h…
The Family Caregiver Survey is a one-time, 30-minute, online survey for people living with and caring for a family member with dementia. The goal of this resear…
ScreenPlus is a consented, multi-disorder pilot newborn screening program implemented in conjunction with the New York State Newborn Screening Program that prov…
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…